growth hormone
8 articles tagged with ‘growth hormone’

CJC-1295 and Ipamorelin Dosage: Evidence and Risks
This reference reviews the evidence on CJC-1295 and ipamorelin dosing, distinguishing what controlled studies support from what remains speculative or vendor-derived.
IGF-1 (Insulin-Like Growth Factor 1): Structure, Signaling, and Research Applications
IGF-1 peptide structure, signaling pathways, and preclinical research applications for laboratory investigation.

Premium Research Peptides: What Defines Research-Grade Quality
Explore what defines research-grade peptide quality, from purity and characterization to evidence standards and safety considerations.

Peptides: What Are They and Why Do They Matter in Research?
A research-focused overview of peptides, their mechanisms, and preclinical evidence for scientific investigators.

BPC-157 vs TB-500: A Comparative Research Analysis of Two Leading Healing Peptides
Compare BPC-157 vs TB-500 for research: mechanisms, wound healing, cardiovascular & GI effects. Scientific analysis for lab use.

CJC-1295 with DAC and Ipamorelin: Growth Hormone Research Guide
CJC-1295 with DAC and Ipamorelin represent key compounds in growth hormone research, targeting distinct pathways for GH and IGF-1 signaling. CJC-1295 with DAC acts as a long-acting GHRH analogue with a half-life of 5.8 to 8.1 days, while Ipamorelin functions as a selective growth hormone secretagogue via the ghrelin receptor. Together, they support studies on metabolism, recovery, and body composition.

Hexarelin: Potent GH Secretagogue Mechanisms and Research
Hexarelin, a synthetic hexapeptide developed in Italy in the early 1990s, stands out for its strong growth hormone pulse amplification among GHRP compounds. Research highlights its action on GHS-R1a receptors and unique cardioprotective effects via CD36 binding, independent of GH release. Studies like Ghigo et al. (1994) and Muccioli et al. (2001) document its potency and distinct pathways, making it valuable for GH axis and cardiac research.

Synergistic Growth Hormone Effects of Sermorelin and Ipamorelin Blend
Research peptides Sermorelin and Ipamorelin may work together to boost growth hormone release from pituitary cells through distinct pathways. Sermorelin mimics the active part of natural GHRH, while Ipamorelin targets GHS-R1a receptors selectively. Laboratory studies indicate this combination could produce higher hGH peaks than either alone, with potential anabolic benefits via IGF-1.